P352: SYMPTOMATIC VTE INCIDENCE IN ADULT ALL TREATED WITH PEG-ASPARAGINASE COMPARED TO THE NATIVE L-ASPARAGINASE IN WITH AN ASPARAGINASE-BASED PROTOCOL. (23rd June 2022) - Chen, R.; Seki, J.; Liu, L.; Atenafu, E.; Yee, K.; Schuh, A.; Gupta, V.; Chan, S.; Schimmer, A.; Maze, D.; Minden, M.; Sibai, H.